Found 30 results
Filters: Keyword is Narcolepsy  [Clear All Filters]
Shan L, Dauvilliers Y, Siegel JM.  2015.  Interactions of the histamine and hypocretin systems in CNS disorders.. Nature Reviews Neurology. 11(7):401-13.
John J, Thannickal TC, McGregor R, Ramanathan L, Ohtsu H, Nishino S, Sakai N, Yamanaka A, Stone C, Cornford M et al..  2013.  Greatly increased numbers of histamine cells in human narcolepsy with cataplexy.. Annals of Neurology. 74(6):786-93.
Scammell TE, Matheson JK, Honda M, Thannickal TC, Siegel JM.  2012.  Coexistence of narcolepsy and Alzheimer's disease.. Neurobiol Aging. 33(7):1318-9.
Siegel JM.  2011.  REM sleep: a biological and psychological paradox.. Sleep Med Rev. 15(3):139-42.
Scammell TE, Willie JT, Guilleminault C, Siegel JM.  2009.  A consensus definition of cataplexy in mouse models of narcolepsy.. Sleep. 32(1):111-6.
Thannickal TC, Nienhuis R, Siegel JM.  2009.  Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.. Sleep. 32(8):993-8.
Siegel JM.  2009.  Narcolepsy. Interview by Norman Sussman.. CNS Spectr. 14(6):295-7.
Siegel JM.  2009.  The neurobiology of sleep.. Semin Neurol. 29(4):277-96.
Siegel JM.  2008.  Gaps that wake you up.. Sleep. 31(12):1625-6.
Thannickal TC, Lai Y-Y, Siegel JM.  2008.  Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease.. Brain. 131(Pt 1):e87.
Siegel JM, Boehmer LN.  2006.  Narcolepsy and the hypocretin system--where motion meets emotion.. Nature Clinical Practice Neurology [Nature Reviews Neurology]. 2(10):548-56.
Blouin AM, Thannickal TC, Worley PF, Baraban JM, Reti IM, Siegel JM.  2005.  Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.. Neurology. 65(8):1189-92.
Siegel JM.  2004.  Hypocretin (orexin): role in normal behavior and neuropathology.. Annual Reviews of Psychology. 55:125-48.
Thannickal TC, Siegel JM, Nienhuis R, Moore RY.  2003.  Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.. Brain Pathology. 13(3):340-51.
Thannickal TC, Moore RY, Aldrich M, Albin R., Cornford M, Siegel JM.  2000.  Human narcolepsy is linked to reduced number, size and synaptic bouton density In hypocretin-2 labeled neurons.. Society for Neuroscience. 25
Siegel JM.  2000.  Narcolepsy. Scientific American. 282
Siegel JM.  2000.  Recent developments in narcolepsy research, an explanation for patients and the general public. Narcolepsy Network Newsletter. :1-2.
Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM.  2000.  Reduced number of hypocretin neurons in human narcolepsy.. Neuron. 27(3):469-74.
John J, Wu MF, Siegel JM.  2000.  Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs.. Sleep Res Online. 3(1):23-8.
Siegel JM.  1999.  Narcolepsy: a key role for hypocretins (orexins). Cell. 98(4):409-12.
Nitz D, Andersen A, Fahringer H, Nienhuis R, Mignot E, Siegel J.  1995.  Altered distribution of cholinergic cells in the narcoleptic dog.. Neuroreport. 6(11):1521-4.
Nishino S, Tafti M, Reid MS, Shelton J, Siegel JM, Dement WC, Mignot E.  1995.  Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.. J Neurosci. 15(7 Pt 1):4806-14.
Reid MS, Tafti M, Geary JN, Nishino S, Siegel JM, Dement WC, Mignot E.  1994.  Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.. Neuroscience. 59(3):511-22.
Reid MS, Siegel JM, Dement WC, Mignot E.  1994.  Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy.. Neuroscience. 59(3):523-30.